FASTinov

FASTinov is a Portuguese precision diagnostics and in vitro diagnostics company focused on ultra-rapid phenotypic antimicrobial susceptibility testing for severe bacterial infections. The company commercializes CE-marked FASTinov AST kits and bioFAST software that use flow cytometry and proprietary analytics to generate susceptibility results directly from positive blood cultures in under two hours. Its products are designed to support faster targeted antibiotic selection, improve sepsis management, and help combat antimicrobial resistance. FASTinov originated as a University of Porto spin-off and has positioned itself as an AI-enabled diagnostics platform company serving clinical microbiology laboratories and hospitals. The company appears to be privately held and commercially active in Europe, with additional geographic expansion planned outside Europe pending regulatory clearance.